Cargando…
The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids
BACKGROUND: The use of corticosteroids (e.g., dexamethasone) as treatment for tendinopathy has recently been questioned as higher risks for ruptures have been observed clinically. In vitro studies have reported that dexamethasone exposed tendon cells, tenocytes, show reduced cell viability and colla...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105245/ https://www.ncbi.nlm.nih.gov/pubmed/27832770 http://dx.doi.org/10.1186/s12891-016-1328-9 |